TrialInvestigational new drugs2013

Pre-operative chemoradiation followed by post-operative adjuvant therapy with tetrathiomolybdate, a novel copper chelator, for patients with resectable esophageal cancer.

Bryan J Schneider et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.